Research News

A new protein as a target for cancer treatment

Any disruption in RNA processing by RNA binding proteins (RBPs) may lead to cancers. This research article published by Natures Communications and helmed by Associate Professor Polly Chen provides insights into the role of a cancer associated protein, DAP3, in cancer development. Findings in this research article suggests that targeting or blocking the protein DAP3 may hold great promise for cancer treatment.

Read more: https://www.nature.com/articles/s41467-022-29400-7#article-info

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Predicting CLL Treatment with BCL-2 Dependence

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow, leading to the buildup …

Read More →
Research News

One Month of Brief Weekly Magnetic Field Therapy Enhances the Anticancer Potential of Female Human Sera

Muscle is our first line of defence against cancer. A randomised clinical trial in Singapore, led by N2CR members A/Prof …

Read More →
Research News

Efficacy of Combined Pembrolizumab and Bevacizumab in Platinum-Resistant Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is common in South China and parts of Southeast Asia. Despite treatment, 20-30% of patients relapse within …

Read More →